Medical Policy Updates

Notification of Policy Revisions Effective January 1, 2011 (Posted September 30, 2011)

Medical Policy	Revision
Gene-Based Tests for Screening, Detection, and/or Management of Prostate Cancer "Notification"	Evidence Based Guideline converted to Corporate Medical Policy. "Description"section updated. "Policy"statement added indicating "Genetic tests for the screening, detection, and management of prostate cancer are considered investigational for all applications. BCBSNC does not provide coverage for investigational services or procedures." Specialty Matched Consultant Advisory Panel review 8/31/2011. References added. Notification given 9/30/2011 Policy effective 1/1/2012.
Gene Expression Testing to Predict Coronary Artery Disease "Notification"	New policy developed. Gene expression testing to predict coronary artery disease is considered investigational. Medical Director review 9/2011. Notice given 9/30/2011 for effective date January 1, 2012.

Medical Policy

Revision

Gene-Based Tests for Screening, Detection, and/or Management of Prostate Cancer "Notification"

Evidence Based Guideline converted to Corporate Medical Policy. "Description"section updated. "Policy"statement added indicating "Genetic tests for the screening, detection, and management of prostate cancer are considered investigational for all applications. BCBSNC does not provide coverage for investigational services or procedures." Specialty Matched Consultant Advisory Panel review 8/31/2011. References added. Notification given 9/30/2011 Policy effective 1/1/2012.

Gene Expression Testing to Predict Coronary Artery Disease "Notification"

New policy developed. Gene expression testing to predict coronary artery disease is considered investigational. Medical Director review 9/2011. Notice given 9/30/2011 for effective date January 1, 2012.